2018-12201. Product Jurisdiction; Correction  

  • Start Preamble Start Printed Page 26392

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Proposed rule; correction.

    SUMMARY:

    The Food and Drug Administration is correcting a proposed rule to amend its regulations concerning the classification of products as biological products, devices, drugs, or combination products, and their assignment to Agency components for premarket review and regulation that appeared in the Federal Register of May 15, 2018. The document was published with an error in the discussion of the preliminary economic analysis impact. This document corrects that error.

    DATES:

    Submit either electronic or written comments on the proposed rule by July 16, 2018.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Melissa Burns, Office of Combination Products, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5129, Silver Spring, MD 20933, 301-796-8930, melissa.burns@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In the Federal Register of Tuesday, May 15, 2018, beginning on page 22428 for FR Doc. 2018-10321, table 1 on page 22433 is corrected to read:

    Table 1—Benefits, Costs, and Distributional Effects of the Proposed Rule 1 2

    CategoryPrimary estimateLow estimateHigh estimateUnitsNotes
    Year dollarsDiscount rate (%)Period covered (years)
    Costs:
    Annualized$17,000$12,000$27,0002016710
    Monetized $/year15,00010,00023,0002016310
    Annualized7
    Quantified3
    Qualitative
    Benefits:
    Annualized28,00025,00089,0002016710
    Monetized $/year28,00025,00089,0002016310
    Annualized7
    Quantified3
    QualitativeFirms and FDA may realize savings from sponsors choosing to submit electronic RFDs
    Transfers:
    Federal7
    Annualized
    Monetized $millions/year3
    From/ToFrom:To:
    Other7
    Annualized
    Monetized $millions/year3
    From/ToFrom:To:
    Effects:
    State, Local or Tribal Government:
    Small Business: Will not have a significant impact on a substantial number of small entities.
    Wages:
    Growth:
    1 We use a 10-year time horizon for this rule with payments occurring at the end of each period.
    2 All dollar values are rounded to the nearest $1,000.
    Start Signature

    Dated: June 1, 2018.

    Leslie Kux,

    Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2018-12201 Filed 6-6-18; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
06/07/2018
Department:
Food and Drug Administration
Entry Type:
Proposed Rule
Action:
Proposed rule; correction.
Document Number:
2018-12201
Dates:
Submit either electronic or written comments on the proposed rule by July 16, 2018.
Pages:
26392-26392 (1 pages)
Docket Numbers:
Docket No. FDA-2004-N-0191
PDF File:
2018-12201.pdf
CFR: (1)
21 CFR 3